CAI
Caris Life Sciences, Inc.
$16.15
-18.60%
2026-05-08
About Caris Life Sciences, Inc.
Caris Life Sciences, Inc., an artificial intelligence TechBio company, provides molecular profiling services in the United States and internationally. It develops and commercializes solutions to transform healthcare using molecular information, and artificial intelligence/machine learning algorithms. The company's molecular intelligence product portfolio includes MI Profile Platform, a whole exome sequencing (WES)/ whole transcriptome sequencing (WTS) tissue-based molecular profiling solutions; Caris Assure Platform WES/WTS blood-based molecular profiling solutions; Precision Whole Genome Platform, a whole genome sequencing (WGS) blood- and tissue-based profiling solutions; and Caris Detect, a WGS-based multi-cancer early detection solution; Caris WGS MRD a WGS and digital droplet polymerase reaction-based minimal residual disease solution; and Caris ChromoSeq, a WGS and WTS based assay for therapy selection in hematological cancers. It also offers pharma research and development services comprising laboratory delivery, strategic data, and research services to biopharmaceutical customers. The company provides its precision oncology solutions to customers, such as hospitals, institutions and patients. The company was founded in 2008 and is headquartered in Irving, Texas.
Key Fundamentals
Forward P/E
43.58
EPS (TTM)
$-3.22
ROE
-45.4%
Revenue Growth (YoY)
125.4%
Profit Margin
-8.4%
Debt/Equity
74.08
Price/Book
8.03
Market Cap
$4.64B
Avg Volume (10D)
1.9M
Recent Breakout Signals
No recent breakout signals detected for CAI.
Recent Price Range (60 Days)
60D High
$22.16
60D Low
$15.71
Avg Volume
2.3M
Latest Close
$16.15
Get breakout alerts for CAI
Sign up for Breakout Scanner to receive daily notifications when CAI triggers breakout signals. Build custom AI screeners and backtest strategies.
Start Free Trial7-day free trial. No card required.
Caris Life Sciences, Inc. (CAI) is listed on the NASDAQ (NASDAQ). Breakout Scanner monitors CAI daily for breakout patterns including long-term ceiling breakouts, momentum breakouts, and near-breakout watch setups. CAI operates in the Healthcare sector within the Biotechnology industry. Data is provided for informational purposes only and does not constitute financial advice.